chlorambucil has been researched along with BLV Infections in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Naito, K | 2 |
Kubo, K | 1 |
Akao, Y | 1 |
Hiraiwa, A | 1 |
Naoe, T | 1 |
Yamada, K | 2 |
Ogawa, T | 1 |
2 other studies available for chlorambucil and BLV Infections
Article | Year |
---|---|
[Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
Topics: Aged; Chlorambucil; Deltaretrovirus Infections; Estradiol; Female; Humans; Lymphoma; Male; Middle Ag | 1986 |
[A case of adult T cell leukemia treated with a new chemotherapeutic agent, KM2210].
Topics: Antigens, Viral; Chlorambucil; Deltaretrovirus Infections; Estradiol; HIV Antigens; Humans; Lymphocy | 1987 |